Sensitivity analysis on a physiologically-based pharmacokinetic and pharmacodynamic model for diisopropylfluorophosphate-induced toxicity in mice and rats

By Chen Kaizhen   Teo Shiyi   Seng Kok-Yong  

Toxicology Mechanisms and Methods, Vol. 19, Iss. 8, 2009-10 ,pp. : 486-497

Informa Healthcare

Access to resources Recommend Favorite

A Population Physiologically Based Pharmacokinetic/Pharmacodynamic Model for the Inhibition of 11- -Hydroxysteroid Dehydrogenase Activity by Glycyrrhetic Acid

By Ploeger B.   Mensinga T.   Sips A.   Deerenberg C.   Meulenbelt J.   DeJongh J.  

Toxicology and Applied Pharmacology, Vol. 170, Iss. 1, 2001-01 ,pp. : 46-55

Elsevier

Access to resources Recommend Favorite

Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model

By Timchalk C.   Kousba A.   Poet T.S.  

Toxicology Letters, Vol. 135, Iss. 1, 2002-09 ,pp. : 51-59

Elsevier

Access to resources Recommend Favorite

Development of a Physiologically Based Pharmacokinetic Model for Hydroquinone

By Corley R.A.   English J.C.   Hill T.S.   Fiorica L.A.   Morgott D.A.  

Toxicology and Applied Pharmacology, Vol. 165, Iss. 2, 2000-06 ,pp. : 163-174

Elsevier

Access to resources Recommend Favorite

The application of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling to understanding the mechanism of action of hazardous substances

By Medinsky M.A.  

Toxicology Letters, Vol. 79, Iss. 1, 1995-09 ,pp. : 185-191

Elsevier

Access to resources Recommend Favorite